Quick Answer
TREACE MEDICAL CONCEPTS, INC. reported Long-Term Debt of $55.58 million for fiscal year 2025.
TREACE MEDICAL CONCEPTS, INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $55.58M | +4.3% |
| 2024 | $53.31M | +0.6% |
| 2023 | $53.01M | +0.6% |
| 2022 | $52.71M | +79.5% |
| 2021 | $29.36M | +0.6% |
| 2020 | $29.19M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $53.53M | +0.6% | +0.1% |
| June 30, 2025 | $53.45M | +0.6% | +0.1% |
| March 31, 2025 | $53.38M | +0.6% | +0.1% |
| December 31, 2024 | $53.31M | +0.6% | +0.1% |
| September 30, 2024 | $53.23M | +0.6% | +0.1% |
| June 30, 2024 | $53.16M | +0.6% | +0.1% |
| March 31, 2024 | $53.08M | +0.6% | +0.1% |
| December 31, 2023 | $53.01M | +0.6% | +0.1% |
- TREACE MEDICAL CONCEPTS, INC. showed an increase of +4.3% in Long-Term Debt compared to the prior fiscal year.
- Over the 2020–2025 period, TREACE MEDICAL CONCEPTS, INC.’s long-term debt has grown by 90.4% (from $29.19 million to $55.58 million).
- The most recent figure is from TREACE MEDICAL CONCEPTS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: